Acute Kidney Injury in Children. An Update on Diagnosis and Treatment.

Pediatric Clinics of North America

Volumn 60, Issue 3, 2013, Pages 669-688

  Fortenberry, James D ^a   Paden, Matthew L ^a   Goldstein, Stuart L ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Acute kidney injury; Continuous renal replacement therapy; Extracorporeal therapies; Fluid overload; Pediatrics; Septic shock

Indexed keywords

ACETYLCYSTEINE; BICARBONATE; CONTRAST MEDIUM; DIURETIC AGENT; DOPAMINE; FENOLDOPAM; FUROSEMIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; THEOPHYLLINE;

ACUTE KIDNEY FAILURE; CHILD; CONTINUOUS RENAL REPLACEMENT THERAPY; DISEASE ASSOCIATION; DISEASE MARKER; DRUG MEGADOSE; HEALTH CARE DELIVERY; HEMODIALYSIS; HUMAN; HYPERVOLEMIA; LOW DRUG DOSE; MORBIDITY; MORTALITY; MULTIPLE ORGAN FAILURE; NEPHROTOXICITY; PATIENT MONITORING; PLASMAPHERESIS; REVIEW; SEPSIS; SEPTIC SHOCK;

EID: 84877034768     PISSN: 00313955     EISSN: 15578240     Source Type: Journal    
DOI: 10.1016/j.pcl.2013.02.006     Document Type: Review

References (107)

1. Ekoynan G. The kidneys in the Bible: what happened?. J Am Soc Nephrol 2005, 16:3464-3471.
2. Kellum J.A., Angus D.C. Patients are dying of acute renal failure. Crit Care Med 2002, 30(2):156-157.
3. Chertow G.M., Burdick E., Honour M., et al. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 2005, 16:3365-3370.
4. Price J.F., Mott A.R., Dickerson H.A., et al. Worsening renal function in children hospitalized with decompensated heart failure: evidence for a pediatric cardiorenal syndrome?. Pediatr Crit Care Med 2008, 9:279-284.
5. Bellomo R., Ronco C., Kellum J.A., et al. Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004, 8:R204-R212.
6. Srisawat N., Hoste E.E., Kellum J.A. Modern classification of acute kidney injury. Blood Purif 2010, 29:300-307.
7. Akcan-Arikan A., Zappitelli M., Loftis L.L., et al. Modified RIFLE criteria in critically ill children with acute kidney injury. Kidney Int 2007, 71:1028-1035.
8. Slater M.B., Anand V., Uleryk E.M., et al. A systematic review of RIFLE criteria in children, and its application and association with measures of mortality and morbidity. Kidney Int 2012, 81:791-798.
9. Mehta R.L., Kellum J.A., Shah S.V., et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007, 11:R31.
10. Blinder J.J., Goldstein S.L., Lee V.V., et al. Congenital heart surgery in infants: effects of acute kidney injury on outcomes. J Thorac Cardiovasc Surg 2012, 143:368-374.
11. Zappitelli M., Bernier P.L., Saczkowski R.S., et al. A small post-operative rise in serum creatinine predicts acute kidney injury in children undergoing cardiac surgery. Kidney Int 2009, 76:885-892.
12. Zappitelli M., Parikh C.R., Akcan-Arikan A., et al. Ascertainment and epidemiology of acute kidney injury varies with definition interpretation. Clin J Am Soc Nephrol 2008, 3:948-954.
13. Kellum J.A., Lamiere N., Aspelin P., et al. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int 2012, 2(Suppl):1-138.
14. Liu K.D., Thompson B.T., Ancukiewicz M., et al. Acute kidney injury in patients with acute lung injury: impact of fluid accumulation on classification of acute kidney injury and associated outcomes. Crit Care Med 2011, 39:2665-2671.
15. Basu RK, Andrews A, Krawczeski CD, et al. Acute kidney injury based on serum creatinine is associated with increased morbidity in children following the arterial switch operation. Pediatr Crit Care Med, in press.
16. Coca S.G., Yalavarthy R., Concato J., et al. Biomarkers for the diagnosis and risk stratification of acute kidney injury: a systematic review. Kidney Int 2008, 73:1008-1016.
17. McMahon B.A., Koyner J.L., Murray P.T. Urinary glutathione S-transferases in the pathogenesis and diagnostic evaluation of acute kidney injury following cardiac surgery: a critical review. Curr Opin Crit Care 2010, 16(6):550-555.
18. Devarajan P. Biomarkers for the early detection of acute kidney injury. Curr Opin Pediatr 2011, 23:194-200.
19. Goldstein S.L. Acute kidney injury biomarkers: renal angina and the need for a renal troponin I. BMC Med 2011, 9:135.
20. Haase M., Bellomo R., Devarajan P., et al. Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis 2009, 54:1012-1024.
21. Krawczeski C.D., Goldstein S.L., Woo J.G., et al. Temporal relationship and predictive value of urinary acute kidney injury biomarkers after pediatric cardiopulmonary bypass. J Am Coll Cardiol 2011, 58:2301-2309.
22. Hui-Stickle S., Brewer E.D., Goldstein S.L. Pediatric ARF epidemiology at a tertiary care center from 1999 to 2001. Am J Kidney Dis 2005, 45:96-101.
23. Moffett B.S., Goldstein S.L. Acute kidney injury and increasing nephrotoxic-medication exposure in noncritically-ill children. Clin J Am Soc Nephrol 2011, 6:856-863.
24. Zappitelli M., Moffett B.S., Hyder A., et al. Acute kidney injury in non-critically ill children treated with aminoglycoside antibiotics in a tertiary healthcare centre: a retrospective cohort study. Nephrol Dial Transplant 2011, 26:144-150.
25. Goldstein S.L., Somers M.J., Baum M.A., et al. Pediatric patients with multi-organ dysfunction syndrome receiving continuous renal replacement therapy. Kidney Int 2005, 67:653-658. 653-65.
26. Symons J.M., Chua A.N., Somers M.J., et al. Demographic characteristics of pediatric continuous renal replacement therapy: a report of the prospective pediatric continuous renal replacement therapy registry. Clin J Am Soc Nephrol 2007, 2:732-738.
27. Hayes L.W., Oster R.A., Tofil N.M., et al. Outcomes of critically ill children requiring continuous renal replacement therapy. J Crit Care 2009, 24:394-400.
28. Foland J.A., Fortenberry J.D., Warshaw B.L., et al. Fluid overload before continuous hemofiltration and survival in critically ill children: a retrospective analysis. Crit Care Med 2004, 32:1771-1776.
29. Basu R., Devarajan P., Wong H., et al. An update and review of acute kidney injury in pediatrics. Pediatr Crit Care Med 2011, 12:339-347.
30. Alkarandi O., Eddington K., Hyder A., et al. Acute kidney injury is an independent risk factor for pediatric intensive care unit mortality, longer length of stay and prolonged mechanical ventilation in critically ill children: a two-center retrospective cohort study. Crit Care 2011, 15:R146.
31. Schneider J., Khemani R., Grushkin C., et al. Serum creatinine as stratified in the RIFLE score for acute kidney injury is associated with mortality and length of stay for children in the pediatric intensive care unit. Crit Care Med 2009, 35:2087-2095.
32. Zapitelli M. Epidemiology and diagnosis of acute kidney injury. Clin Nephrol 2009, 71:602-607.
33. Brophy P.D. Renal supportive therapy for pediatric acute kidney injury in the setting of multiorgan dysfunction syndrome/sepsis. Semin Nephrol 2008, 28:457-469.
34. Prodhan P., McCage L., Stroud M., et al. Acute kidney injury is associated with in-hospital mortality in mechanically ventilated children with trauma. J Trauma Acute Care Surg 2012, 73:832-837.
35. Askenazi D., Ambalavanan N., Hamilton K., et al. Acute kidney injury and renal replacement therapy independently predict mortality in neonatal and pediatric noncardiac patients on extracorporeal membrane oxygenation. Pediatr Crit Care Med 2011, 12:e1-e6.
36. Askenazi D., Feig D., Graham N., et al. 3-5 year longitudinal follow-up of pediatric patients after acute renal failure. Kidney Int 2006, 69:184-189.
37. Ronco C., Kellum J.A., Bellomo R., et al. Potential interventions in sepsis-related acute kidney injury. Clin J Am Soc Nephrol 2008, 3:531-544.
38. Wan L., Bagshaw S.M., Langenberg C., et al. Pathophysiology of septic acute kidney injury: what do we really know?. Crit Care Med 2008, 36:S198-S203.
39. Bagshaw S.M., George C., Bellomo R. Early acute kidney injury and sepsis: a multicentre evaluation. Crit Care 2008, 12:R47.
40. Shaheen I.S., Watson A., Harvey B. Acute renal failure in children: etiology, treatment and outcome. Saudi J Kidney Dis Transpl 2006, 17:153-158.
41. Loza R., Estremadoyro L., Loza C., et al. Factors associated with mortality in acute renal failure in children. Pediatr Nephrol 2006, 21:106-109.
42. Bellomo R., Wan L., Langenberg C., et al. Septic acute kidney injury: new concepts. Nephron Exp Nephrol 2008, 109:e95-e100.
43. Ronco C., Tetta C., Mariano F., et al. Interpreting the mechanisms of continuous renal replacement therapy in sepsis. The peak concentration hypothesis. Artif Organs 2003, 27:792-801.
44. Nguyen T.C., Han Y., Kiss J.E., et al. Intensive plasma exchange increases a disintegrin and metalloprotease with thrombospondin motifs-13 activity and reverses organ dysfunction in children with thrombocytopenia-associated multiple organ failure. Crit Care Med 2008, 36:2878-2887.
45. Haase-Fielitz A., Haase M., Bellomo R., et al. Genetic polymorphisms in sepsis- and cardiopulmonary bypass-associated acute kidney injury. Contrib Nephrol 2007, 156:75-91.
46. Jaber B.L., Rao M., Guo D., et al. Cytokine gene polymorphisms and mortality in acute renal failure. Cytokine 2004, 25:212-219.
47. Basu R.K., Standage S., Cvijanovich N., et al. Identification of candidate serum biomarkers for severe septic shock-associated kidney injury via microarray. Crit Care 2011, 15:R273.
48. Watson R.S., Carcillo J.A., Linde-Zwirble W.T., et al. The epidemiology of severe sepsis in children of the United States. Am J Respir Crit Care Med 2003, 167:695-701.
49. Jefferies J., Goldstein S. Cardiorenal syndrome: an emerging problem in pediatric critical care. Pediatr Nephrol 2012, [Epub ahead of print].
50. Hassinger A., Backer C., Lane J., et al. Predictive power of serum cystatin C to detect kidney injury and pediatric-modified RIFLE class in children undergoing cardiac surgery. Pediatr Crit Care Med 2012, 13:435-440.
51. Wadei H., Martin M., Ahsan N. Hepatorenal syndrome: pathophysiology and management. Clin J Am Soc Nephrol 2006, 1:1066-1079.
52. Fortenberry J.D. Fluid overload and outcomes in pediatric critical illness. Current concepts in pediatric critical care 2012, 71-81. Society of Critical Care Medicine, Chicago.
53. Goldstein S., Brewer E., Currier H., et al. Outcome in children receiving continuous venovenous hemofiltration. Pediatrics 2001, 107:1309.
54. Gillespie R., Seidel K., Symons J. Effect of fluid overload and dose of replacement fluid on survival in hemofiltration. Pediatr Nephrol 2004, 19:1394-1399.
55. Sutherland S.M., Zappitelli M., Alexander S.R., et al. Fluid overload and mortality in children receiving continuous renal replacement therapy: The prospective pediatric continuous renal replacement therapy registry. Am J Kidney Dis 2010, 55:316-325.
56. Ray K. Fluid overload increases mortality in critically ill children. Nat Rev Nephrol 2010, 6:190.
57. Payen D., Cornélie de Pont A., Sakr Y., et al. A positive fluid balance is associated with a worse outcome in patients with acute renal failure. Crit Care 2008, 12:R74.
58. Bouchard J., Soroko S.B., Chertow G.M., et al. Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury. Kidney Int 2009, 76:422-427.
59. Bagshaw S.M., Delaney A., Haase M., et al. Loop diuretics in the management of acute renal failure: a systematic review and meta-analysis. Crit Care Resusc 2007, 9:60-68.
60. Tepel M., van der Giet M., Schwarzfeld C., et al. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 2000, 343:180-184.
61. ACT Investigators Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized Acetylcysteine for Contrast-induced nephropathy Trial (ACT). Circulation 2011, 124:1250-1259.
62. Friedrich J.O., Adhikari N., Herridge M.S., et al. Meta-analysis: low-dose dopamine increases urine output but does not prevent renal dysfunction or death. Ann Intern Med 2005, 142:510-524.
63. Bagshaw S.M., Lapinsky S., Dial S., et al. Cooperative Antimicrobial Therapy of Septic Shock (CATSS) Database Research Group. Acute kidney injury in septic shock: clinical outcomes and impact of duration of hypotension prior to initiation of antimicrobial therapy. Intensive Care Med 2009, 35:871-881.
64. Ricci Z., Luciano R., Favia I., et al. High-dose fenoldopam reduces postoperative neutrophil gelatinase-associated lipocaline and cystatin C levels in pediatric cardiac surgery. Crit Care 2011, 15:R160.
65. Goldstein S.L. A novel use for novel acute kidney injury biomarkers: fenoldopam's effect on neutrophil gelatinase-associated lipocalin and cystatin C. Crit Care 2011, 15:177.
66. Van den Berghe G., Wouters P., Weekers F., et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001, 345:1359-1367.
67. Hansen T.K., Thiel S., Wouters P.J., et al. Intensive insulin therapy exerts anti-inflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels. J Clin Endocrinol Metab 2003, 88:1082-1088.
68. Allen D.A., Harwood S., Varagunam M., et al. High glucose-induced oxidative stress causes apoptosis in proximal tubular epithelial cells and is mediated by multiple caspases. FASEB J 2003, 17:908-910.
69. Van den Berghe G., Wilmer A., Hermans G., et al. Intensive insulin therapy in the medical ICU. N Engl J Med 2006, 354:449-461.
70. NICE-SUGAR Study Investigators, Finfer S., Chittock D.R., et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009, 360:1283-1297.
71. Vlasselaers D., Milants I., Desmet L., et al. Intensive insulin therapy for patients in paediatric intensive care: a prospective, randomized controlled study. Lancet 2009, 373:547-556.
72. Agus M.S., Steil G., Wypij D., et al. Tight glycemic control versus standard care after pediatric cardiac surgery. N Engl J Med 2012, 367:1208-1219.
73. Sutherland S., Alexander S. Continuous renal replacement therapy in children. Pediatr Nephrol 2012, 27:2007-2016.
74. Goldstein S.L. Advances in pediatric renal replacement therapy for acute kidney injury. Semin Dial 2011, 24:187-191.
75. Bellomo R., Tipping P., Boyce N. Continuous veno-venous hemofiltration with dialysis removes cytokines from the circulation of septic patients. Crit Care Med 1993, 21:522-526.
76. Murray P., Udani S., Koyner J.L. Does renal replacement therapy improve outcome? Controversies in acute kidney injury. Contrib Nephrol 2011, 174:212-221.
77. Palevsky P., Zhang J., O'Connor T., et al. Intensity of continuous renal replacement therapy in critically ill patients. N Engl J Med 2008, 361:1627-1628.
78. Goldstein S.L., Somers M.J., Brophy P.D., et al. The prospective pediatric continuous renal replacement therapy registry: design, development and data assessed. Int J Artif Organs 2004, 27:9-14.
79. Ronco C., Bellomo R., Homel P., et al. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet 2000, 356:26.
80. Talwani A.J., Campbell R.C., Stofan B., et al. Standard versus high-dose CVVHDF for ICU-related acute renal failure. J Am Soc Nephrol 2008, 19:1233-1238.
81. Bellomo R., Cass A., Cole L., et al. Intensity of continuous renal replacement therapy in critically ill patients. N Engl J Med 2009, 361:1627-1638.
82. Brophy P., Somers M.J., Baum M., et al. Multi-centre evaluation of anticoagulation in patients receiving continuous renal replacement therapy (CRRT). Nephrol Dial Transplant 2005, 20:1416-1421.
83. Bunchman T., Maxvold N., Barnett J., et al. Pediatric hemofiltration: normocarb dialysate solution with citrate anticoagulation. Pediatr Nephrol 2002, 17:150-154.
84. Rock G.A., Shumak K., Buskard N. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. N Engl J Med 1991, 325:393-397.
85. Fortenberry J.D., Paden M. Extracorporeal therapies in the treatment of sepsis: experience and promise. Semin Pediatr Infect Dis 2006, 17:72-79.
86. Fortenberry J.D., Nguyen T., Toney R., et al. Organ dysfunction and experience with plasma exchange in children with thrombocytopenia-associated multiple organ failure (TAMOF): findings of the prospective Children's TAMOF Network. Crit Care Med 2010, 38:A30.
87. Roy B.J., Cornish J.D., Clark R.H. Venovenous extracorporeal membrane oxygenation affects renal function. Pediatrics 1995, 95:573-578.
88. Heiss K.F., Pettit B., Hirschl R.B., et al. Renal insufficiency and volume overload in neonatal ECMO managed by continuous ultrafiltration. Trans Am Soc Artif Intern Organs 1987, 33:557-559.
89. Sell L.L., Cullen M.L., Whittlesey G.C., et al. Experience with renal failure during extracorporeal membrane oxygenation: treatment with continuous hemofiltration. J Pediatr Surg 1987, 22:600-602.
90. Zwischenberger J.B., Nguyen T.T., Upp J.R., et al. Complications of neonatal extracorporeal membrane oxygenation. Collective experience from the Extracorporeal Life Support Organization. J Thorac Cardiovasc Surg 1994, 107:838-848.
91. Zahraa J.N., Moler F.W., Annich G.M., et al. Venovenous versus venoarterial extracorporeal life support for pediatric respiratory failure: are there differences in survival and acute complications?. Crit Care Med 2000, 28:521-525.
92. Paden M.L., Warshaw B.L., Heard M.L., et al. Recovery of renal function and survival after continuous renal replacement therapy during extracorporeal membrane oxygenation. Pediatr Crit Care Med 2011, 12:153-158.
93. Yap H.J., Chen Y.C., Fang J.T., et al. Combination of continuous renal replacement therapies (CRRT) and extracorporeal membrane oxygenation for advanced cardiac patients. Ren Fail 2003, 25:183-193.
94. Smith A.H., Hardison D.C., Worden C.R., et al. Acute renal failure during extracorporeal support in the pediatric cardiac patient. ASAIO J 2009, 55:412-416.
95. Robertson C.M., Tyebkhan J.M., Peliowski A., et al. Ototoxic drugs and sensorineural hearing loss following severe neonatal respiratory failure. Acta Paediatr 2006, 95:214-223.
96. Marik P.E., Zaloga G.P. Early enteral nutrition in acutely ill patients: a systematic review. Crit Care Med 2001, 29:2264-2270.
97. Hoover N.G., Heard M., Reid C., et al. Enhanced fluid management with continuous venovenous hemofiltration in pediatric respiratory failure patients receiving extracorporeal membrane oxygenation support. Intensive Care Med 2008, 34:2241-2247.
98. Fleming F.M., Askenazi D.J., Bridges B.C., et al. A multicenter international survey of renal supportive therapy during ECMO: The Kidney Intervention During Extracorporeal Membrane Oxygenation (KIDMO) Group. ASAIO J 2012, 58:404-414.
99. Extracorporeal Life Support Organization. Guidelines. Available at: . Accessed November 26, 2012. http://www.elsonet.org/index.php/resources/guidelines.html.
100. Kelly R.E., Phillips J.D., Foglia R.P., et al. Pulmonary edema and fluid mobilization as determinants of the duration of ECMO support. J Pediatr Surg 1991, 26:1016-1022.
101. Meyer R.J., Brophy P.D., Bunchman T.E., et al. Survival and renal function in pediatric patients following extracorporeal life support with hemofiltration. Pediatr Crit Care Med 2001, 2:238-242.
102. Askenazi D.J., Selewski D.T., Paden M.L., et al. Renal replacement therapy in critically ill patients receiving extracorporeal membrane oxygenation. Clin J Am Soc Nephrol 2012, 7:1328-1336.
103. Bridges B.C., Selewski D.T., Paden M.L., et al. Acute kidney injury in neonates requiring ECMO. Neoreviews 2012, 13:e428-e433.
104. Weber T.R., Kountzman B. Extracorporeal membrane oxygenation for nonneonatal pulmonary and multiple-organ failure. J Pediatr Surg 1998, 33:1605-1609.
105. Jenkins R., Harrison H., Chen B., et al. Accuracy of intravenous infusion pumps in continuous renal replacement therapies. ASAIO J 1992, 38:808-810.
106. Sucosky P., Dasi L.P., Goldman S.L., et al. Assessment of current continuous hemofiltration systems and development of a novel accurate fluid management system for use in extracorporeal membrane oxygenation. J Med Device 2008, 2:35002-35010.
107. Santiago M.J., Sánchez A., López-Herce J., et al. The use of continuous renal replacement therapy in series with extracorporeal membrane oxygenation. Kidney Int 2009, 76:1289-1292.